Patent 7642358 was granted and assigned to Metabolex on January, 2010 by the United States Patent and Trademark Office.
Substituted phenylacetic acids, phenylethanols and related compounds are provided that are useful in treating or controlling a number of diseases associated with glucose metabolism, lipid metabolism and insulin secretion.